Literature DB >> 27061826

Anti-programmed cell death-1 therapy in nonmelanoma skin cancer.

J K Winkler1, R Schneiderbauer1, C Bender1, O Sedlaczek2, S Fröhling3,4, R Penzel5, A Enk1, J C Hassel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27061826     DOI： 10.1111/bjd.14664

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  25 in total

Review 1.  Advanced basal cell cancer: concise review of molecular characteristics and novel targeted and immune therapeutics.

Authors:  M Nikanjam; P R Cohen; S Kato; J K Sicklick; R Kurzrock
Journal:  Ann Oncol       Date:  2018-11-01       Impact factor: 32.976

Review 2.  Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma.

Authors:  Dai Ogata; Tetsuya Tsuchida
Journal:  Curr Treat Options Oncol       Date:  2019-03-14

Review 3.  Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond.

Authors:  Anshika Bakshi; Sandeep C Chaudhary; Mehtab Rana; Craig A Elmets; Mohammad Athar
Journal:  Mol Carcinog       Date:  2017-08-22       Impact factor: 4.784

Review 4.  Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management.

Authors:  Piyu Parth Naik; Munaf B Desai
Journal:  Oncol Ther       Date:  2022-06-21

Review 5.  Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response.

Authors:  Enrico Zelin; Carlo Alberto Maronese; Arianna Dri; Ludovica Toffoli; Nicola Di Meo; Gianluca Nazzaro; Iris Zalaudek
Journal:  J Clin Med       Date:  2022-06-11       Impact factor: 4.964

6.  Differential expression of programmed cell death ligand 1 (PD-L1) and inflammatory cells in basal cell carcinoma subtypes.

Authors:  Sergio Gonzalez; Pablo Uribe; Cristian Navarrete-Dechent; Matias Gompertz-Mattar; Juan Perales; Aditi Sahu; Sebastián Mondaca
Journal:  Arch Dermatol Res       Date:  2021-10-13       Impact factor: 3.033

Review 7.  [Cutaneous squamous cell carcinoma].

Authors:  U Leiter; R Gutzmer; M Alter; C Ulrich; A S Lonsdorf; M M Sachse; U Hillen
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

8.  Topical arginase inhibition decreases growth of cutaneous squamous cell carcinoma.

Authors:  Amit Mittal; Mike Wang; Aurobind Vidyarthi; Diana Yanez; Gabriela Pizzurro; Durga Thakral; Erin Tracy; Oscar R Colegio
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.996

9.  Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810.

Authors:  Gerald S Falchook; Rom Leidner; Elizabeth Stankevich; Brian Piening; Carlo Bifulco; Israel Lowy; Matthew G Fury
Journal:  J Immunother Cancer       Date:  2016-11-15       Impact factor: 13.751

Review 10.  Immune checkpoint inhibitors to treat cutaneous malignancies.

Authors:  Dulce M Barrios; Mytrang H Do; Gregory S Phillips; Michael A Postow; Tomoko Akaike; Paul Nghiem; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2020-05-24       Impact factor: 11.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.